Pacer Advisors, Inc. Alkermes Plc. Transaction History
Pacer Advisors, Inc.
- $38.6 Billion
- Q1 2024
A detailed history of Pacer Advisors, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 4,278,563 shares of ALKS stock, worth $100 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
4,278,563
Previous 770
555557.53%
Holding current value
$100 Million
Previous $21,000
551423.81%
% of portfolio
0.3%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$683 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$472 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$348 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$211 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$195 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.84B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...